Contemporary issues in the management of pediatric infections

Pediatric Infectious Disease Journal

Volumn 16, Issue 3 SUPPL., 1997, Pages

  Helwig, Helmut ^a,b  

^a St Hedwig Hospital   (Germany)

^b NONE   (Germany)

Author keywords

antibiotic; children; community acquired; Infection

Indexed keywords

CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; VANCOMYCIN;

BACTERIAL INFECTION; CHILDHOOD DISEASE; CONFERENCE PAPER; DRUG CHOICE; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; LABORATORY DIAGNOSIS; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; TONSILLITIS; URINARY TRACT INFECTION;

EID: 0030933614     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199703001-00003     Document Type: Conference Paper

References (19)

1. Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis 1992;11:217-23.
2. Anderson LJ, Parker RA, Strikas RA, et al. Day-care center attendance and hospitalization for lower respiratory tract illness. Pediatrics 1988;82:300-8.
3. Hurwitz ES, Gunn WJ, Pinsky PF, Schonberger LB. Risk of respiratory illness associated with day-care attendance: a nationwide study. Pediatrics 1991;87:62-9.
4. Rosenfeld RM. What to expect from medical treatment of otitis media. Pediatr Infect Dis J 1995;14:731-8.
5. Helwig H. Die Pneumonie im Kindesalter: Ursachen und Behandlungsstrategien. Kinderarzt 1995;26:508-17.
6. Otitis media update. Presented at the First International Pediatric Infectious Disease Conference, Monterey, CA, September, 1995.
7. Paradiese JL. Managing otitis media: a time for change. Pediatrics 1995;4:712-5.
8. Ginsburg DM, McCracken GH, Petruska M. Once-daily cefadroxil versus twice-daily cefaclor for treatment of acute urinary tract infections in children. J Antimicrob Chemother 1982;10:53-6.
9. Alpert G, Hippert E, Fleisher GR. Case-control study of hyperpyrexia in children. Pediatr Infect Dis J 1990;9:161-3.
10. Hull D. Fever: the fire of life. Arch Dis Child 1989;64:1741-7.
11. Helwig H. Der hyperpyretische Infekt beim Säugling und Kleinkind. Pädiatr Prax 1991;42:223-9.
12. Wiedemann B. Die antimikrobielle Wirkung von Ceftibuten. Chemother J 1994;3(Suppl 3):6-11.
13. Wiseman LR, Balfour JA. Ceftibuten: a review of its antibacterial activity, pharmacokinetic properties, and clinical efficacy. Drugs 1994;47:784-808.
14. Spector S. Review of the properties and features of ceftibuten: a new orally active antibiotic. Infect Dis Clin Pract 1995;4:1-11.
15. Pichichero ME, McLinn SE, Gooch WM, et al. Ceftibuten vs. penicillin V in Group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J 1993;12:64-70.
16. Kammer RB. Worldwide safety experience with ceftibuten pediatric suspension. Pediatr Infect Dis J 1993;12:92-4.
17. Helwig H. Neuere Oralcephalosporine unter besonderer Berücksichtigung von Ceftibuten. Chemother J 1994;3(Suppl 3): 1-5.
18. Jones RN. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features. Pediatr Infect Dis J 1995;14:S77-83.
19. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher RW. Determinants of non-compliance with short-term antibiotic regimens. Br Med J 1987;295:814-8.